Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway

Yanqin Gao, Armando P. Signore, Wei Yin, Guodong Cao, Xiao Ming Yin, Fengyan Sun, Yumin Luo, Steven H. Graham, Jun Chen

Research output: Contribution to journalArticle

186 Citations (Scopus)

Abstract

c-Jun N-terminal kinase (JNK) is an important stress-responsive kinase that is activated by various forms of brain insults. In this study, we have examined the role of JNK activation in neuronal cell death in a murine model of focal ischemia and reperfusion; furthermore, we investigated the mechanism of JNK in apoptosis signaling, focusing on the mitochondrial-signaling pathway. We show here that JNK activity was induced in the brain 0.5 to 24 h after ischemia. Systemic administration of SP600125, a small molecule JNK-specific inhibitor, diminished JNK activity after ischemia and dose-dependently reduced infarct volume. c-Jun N-terminal kinase inhibition also attenuated ischemia-induced expression of Bim, Hrk/DP5, and Fas, but not the expression of Bcl-2 or FasL. In strong support of a role for JNK in promoting the mitochondrial apoptosis-signaling pathway, JNK inhibition prevented ischemia-induced mitochondrial translocation of Bax and Bim, release of cytochrome c and Smac, and activation of caspase-9 and caspase-3. The potential mechanism by which JNK promoted Bax translocation after ischemia was further studied using coimmunoprecipitation, and the results revealed that JNK activation caused serine phosphorylation of 14-3-3, a cytoplasmic sequestration protein of Bax, leading to Bax disassociation from 14-3-3 and subsequent translocation to mitochondria. These results confirm the role of JNK as a critical cell death mediator in ischemic brain injury, and suggest that one of the mechanisms by which JNK triggers the mitochondrial apoptosis-signaling pathway is via promoting Bax and Bim translocation.

Original languageEnglish (US)
Pages (from-to)694-712
Number of pages19
JournalJournal of Cerebral Blood Flow and Metabolism
Volume25
Issue number6
DOIs
StatePublished - Jun 1 2005

Fingerprint

JNK Mitogen-Activated Protein Kinases
Brain Injuries
Apoptosis
Ischemia
Neuroprotection
Cell Death
bcl-2-Associated X Protein
Caspase 9
Brain
Cytochromes c
Caspase 3
Serine
Reperfusion
Mitochondria
Phosphotransferases

Keywords

  • Bax
  • Bim
  • Caspase-3
  • Caspase-9
  • Cytochrome c

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. / Gao, Yanqin; Signore, Armando P.; Yin, Wei; Cao, Guodong; Yin, Xiao Ming; Sun, Fengyan; Luo, Yumin; Graham, Steven H.; Chen, Jun.

In: Journal of Cerebral Blood Flow and Metabolism, Vol. 25, No. 6, 01.06.2005, p. 694-712.

Research output: Contribution to journalArticle

Gao, Yanqin ; Signore, Armando P. ; Yin, Wei ; Cao, Guodong ; Yin, Xiao Ming ; Sun, Fengyan ; Luo, Yumin ; Graham, Steven H. ; Chen, Jun. / Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. In: Journal of Cerebral Blood Flow and Metabolism. 2005 ; Vol. 25, No. 6. pp. 694-712.
@article{e05880921b794801a34740a0a24d2c15,
title = "Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway",
abstract = "c-Jun N-terminal kinase (JNK) is an important stress-responsive kinase that is activated by various forms of brain insults. In this study, we have examined the role of JNK activation in neuronal cell death in a murine model of focal ischemia and reperfusion; furthermore, we investigated the mechanism of JNK in apoptosis signaling, focusing on the mitochondrial-signaling pathway. We show here that JNK activity was induced in the brain 0.5 to 24 h after ischemia. Systemic administration of SP600125, a small molecule JNK-specific inhibitor, diminished JNK activity after ischemia and dose-dependently reduced infarct volume. c-Jun N-terminal kinase inhibition also attenuated ischemia-induced expression of Bim, Hrk/DP5, and Fas, but not the expression of Bcl-2 or FasL. In strong support of a role for JNK in promoting the mitochondrial apoptosis-signaling pathway, JNK inhibition prevented ischemia-induced mitochondrial translocation of Bax and Bim, release of cytochrome c and Smac, and activation of caspase-9 and caspase-3. The potential mechanism by which JNK promoted Bax translocation after ischemia was further studied using coimmunoprecipitation, and the results revealed that JNK activation caused serine phosphorylation of 14-3-3, a cytoplasmic sequestration protein of Bax, leading to Bax disassociation from 14-3-3 and subsequent translocation to mitochondria. These results confirm the role of JNK as a critical cell death mediator in ischemic brain injury, and suggest that one of the mechanisms by which JNK triggers the mitochondrial apoptosis-signaling pathway is via promoting Bax and Bim translocation.",
keywords = "Bax, Bim, Caspase-3, Caspase-9, Cytochrome c",
author = "Yanqin Gao and Signore, {Armando P.} and Wei Yin and Guodong Cao and Yin, {Xiao Ming} and Fengyan Sun and Yumin Luo and Graham, {Steven H.} and Jun Chen",
year = "2005",
month = "6",
day = "1",
doi = "10.1038/sj.jcbfm.9600062",
language = "English (US)",
volume = "25",
pages = "694--712",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway

AU - Gao, Yanqin

AU - Signore, Armando P.

AU - Yin, Wei

AU - Cao, Guodong

AU - Yin, Xiao Ming

AU - Sun, Fengyan

AU - Luo, Yumin

AU - Graham, Steven H.

AU - Chen, Jun

PY - 2005/6/1

Y1 - 2005/6/1

N2 - c-Jun N-terminal kinase (JNK) is an important stress-responsive kinase that is activated by various forms of brain insults. In this study, we have examined the role of JNK activation in neuronal cell death in a murine model of focal ischemia and reperfusion; furthermore, we investigated the mechanism of JNK in apoptosis signaling, focusing on the mitochondrial-signaling pathway. We show here that JNK activity was induced in the brain 0.5 to 24 h after ischemia. Systemic administration of SP600125, a small molecule JNK-specific inhibitor, diminished JNK activity after ischemia and dose-dependently reduced infarct volume. c-Jun N-terminal kinase inhibition also attenuated ischemia-induced expression of Bim, Hrk/DP5, and Fas, but not the expression of Bcl-2 or FasL. In strong support of a role for JNK in promoting the mitochondrial apoptosis-signaling pathway, JNK inhibition prevented ischemia-induced mitochondrial translocation of Bax and Bim, release of cytochrome c and Smac, and activation of caspase-9 and caspase-3. The potential mechanism by which JNK promoted Bax translocation after ischemia was further studied using coimmunoprecipitation, and the results revealed that JNK activation caused serine phosphorylation of 14-3-3, a cytoplasmic sequestration protein of Bax, leading to Bax disassociation from 14-3-3 and subsequent translocation to mitochondria. These results confirm the role of JNK as a critical cell death mediator in ischemic brain injury, and suggest that one of the mechanisms by which JNK triggers the mitochondrial apoptosis-signaling pathway is via promoting Bax and Bim translocation.

AB - c-Jun N-terminal kinase (JNK) is an important stress-responsive kinase that is activated by various forms of brain insults. In this study, we have examined the role of JNK activation in neuronal cell death in a murine model of focal ischemia and reperfusion; furthermore, we investigated the mechanism of JNK in apoptosis signaling, focusing on the mitochondrial-signaling pathway. We show here that JNK activity was induced in the brain 0.5 to 24 h after ischemia. Systemic administration of SP600125, a small molecule JNK-specific inhibitor, diminished JNK activity after ischemia and dose-dependently reduced infarct volume. c-Jun N-terminal kinase inhibition also attenuated ischemia-induced expression of Bim, Hrk/DP5, and Fas, but not the expression of Bcl-2 or FasL. In strong support of a role for JNK in promoting the mitochondrial apoptosis-signaling pathway, JNK inhibition prevented ischemia-induced mitochondrial translocation of Bax and Bim, release of cytochrome c and Smac, and activation of caspase-9 and caspase-3. The potential mechanism by which JNK promoted Bax translocation after ischemia was further studied using coimmunoprecipitation, and the results revealed that JNK activation caused serine phosphorylation of 14-3-3, a cytoplasmic sequestration protein of Bax, leading to Bax disassociation from 14-3-3 and subsequent translocation to mitochondria. These results confirm the role of JNK as a critical cell death mediator in ischemic brain injury, and suggest that one of the mechanisms by which JNK triggers the mitochondrial apoptosis-signaling pathway is via promoting Bax and Bim translocation.

KW - Bax

KW - Bim

KW - Caspase-3

KW - Caspase-9

KW - Cytochrome c

UR - http://www.scopus.com/inward/record.url?scp=18944381512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18944381512&partnerID=8YFLogxK

U2 - 10.1038/sj.jcbfm.9600062

DO - 10.1038/sj.jcbfm.9600062

M3 - Article

C2 - 15716857

AN - SCOPUS:18944381512

VL - 25

SP - 694

EP - 712

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 6

ER -